1
Return

Exploring new treatment strategies for hard-to-treat double-hit and double-expressor lymphomas

delete2025-10-13
delete0
delete
OA
AI
M
Max F. Kelsten *
R
Reem Karmali *
DOI:10.1080/1750743X.2025.2572956delete
deleteOriginal
deleteShare
deleteSave
View PDF
Abstract

Abstract

En 中文
Double-hit (DHL) and double-expressor (DEL) large B-cell lymphomas (LBCL) are relatively rare, with the former occurring in 5–12% of LBCL and the latter in up to a third [1]. Despite this, their as...
Keywords:
Lymphoma
double-hit
double-expressor
DLBCL
cellular therapy
CAR-T
AI Summary

AI Summary

Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.

Journal

J
Journal of Immunotherapy
IF:
2.9
Papers:
2.1K
Citations:
3.2K

Organization

N
Northwestern University
Scholars:
6.1W
Papers: 5.2W
Citations: 3.9K
Cited Papers

Cited Papers

Citing Papers

Citing Papers